# Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)

> **NCT05989932** · — · COMPLETED · sponsor: **Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse** · enrollment: 146 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **OTHER:** Upadacitinib

## Key facts

- **NCT ID:** NCT05989932
- **Lead sponsor:** Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-15
- **Primary completion:** 2024-04-19
- **Final completion:** 2024-04-19
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05989932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05989932, "Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05989932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*